James S. Scibetta, SVP, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 15,000 shares at $86.13 ($1.3M) on 2014-11-07, disclosed to the SEC on 2014-11-12.
Scheduled sale ($1.3M) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.13 | 2,300 | $198K | 15.1% |
| 2 | $86.99 | 8,600 | $748K | 57.2% |
| 3 | $87.65 | 3,100 | $272K | 20.8% |
| 4 | $89.56 | 800 | $72K | 5.5% |
| 5 | $90.33 | 200 | $18K | 1.4% |
| Total | $87.18 avg | 15,000 |
| $1.3M |
| 100% |
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |